These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8139533)

  • 1. Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene.
    Press RD; Reddy EP; Ewert DL
    Mol Cell Biol; 1994 Apr; 14(4):2278-90. PubMed ID: 8139533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.
    Press RD; Wisner TW; Ewert DL
    Oncogene; 1995 Aug; 11(3):525-35. PubMed ID: 7630637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein truncation is required for the activation of the c-myb proto-oncogene.
    Grässer FA; Graf T; Lipsick JS
    Mol Cell Biol; 1991 Aug; 11(8):3987-96. PubMed ID: 2072904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation.
    Mukhopadhyaya R; Wolff L
    J Virol; 1992 Oct; 66(10):6035-44. PubMed ID: 1527851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma.
    Jiang W; Kanter MR; Dunkel I; Ramsay RG; Beemon KL; Hayward WS
    J Virol; 1997 Sep; 71(9):6526-33. PubMed ID: 9261372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an inducible regulator of c-myb expression during T-cell activation.
    Phan SC; Feeley B; Withers D; Boxer LM
    Mol Cell Biol; 1996 May; 16(5):2387-93. PubMed ID: 8628306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
    Bies J; Mukhopadhyaya R; Pierce J; Wolff L
    Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.
    Hu YL; Ramsay RG; Kanei-Ishii C; Ishii S; Gonda TJ
    Oncogene; 1991 Sep; 6(9):1549-53. PubMed ID: 1923521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myb-induced transformation.
    Wolff L
    Crit Rev Oncog; 1996; 7(3-4):245-60. PubMed ID: 9258605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
    Rascle A; Ferrand N; Gandrillon O; Samarut J
    Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential transforming-ability by internal deletion of the bovine c-myb gene.
    Ohozono T; Ishiguro N; Horiuchi M; Shinagawa M
    J Vet Med Sci; 1996 Apr; 58(4):305-10. PubMed ID: 8741261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein.
    Ghysdael J; Gegonne A; Pognonec P; Dernis D; Leprince D; Stehelin D
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1714-8. PubMed ID: 3006066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of chicken embryo fibroblast cells by avian retroviruses containing the human Fyn gene and its mutated genes.
    Semba K; Kawai S; Matsuzawa Y; Yamanashi Y; Nishizawa M; Toyoshima K
    Mol Cell Biol; 1990 Jun; 10(6):3095-104. PubMed ID: 2188108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine myeloid cell lines derived by in vitro infection with recombinant c-myb retroviruses express myb from rearranged vector proviruses.
    Gonda TJ; Ramsay RG; Johnson GR
    EMBO J; 1989 Jun; 8(6):1767-75. PubMed ID: 2670561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
    Bies J; Wolff L
    Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The c-Myb oncoprotein.
    Gonda TJ
    Int J Biochem Cell Biol; 1998 May; 30(5):547-51. PubMed ID: 9693954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
    Dubendorff JW; Lipsick JS
    Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in specific DNA binding by carboxyl truncation suggests a mechanism for activation of Myb.
    Ramsay RG; Ishii S; Gonda TJ
    Oncogene; 1991 Oct; 6(10):1875-9. PubMed ID: 1923510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias.
    Bies J; Nazarov V; Wolff L
    J Virol; 1999 Mar; 73(3):2038-44. PubMed ID: 9971784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo.
    Dini PW; Lipsick JS
    Mol Cell Biol; 1993 Dec; 13(12):7334-48. PubMed ID: 8246954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.